SU‐E‐T‐184: Usefulness of Triple Channel Correction for Gafchromic EBT2 Film on Patient Specific Quality Assurance of IMRT and IMAT

Abstract

Purpose: Triple channel correction acquisition (TCCA) is a model‐based method for obtaining the characteristic curve of Gafchromic EBT2 film (EBT2). In this study the TCCA method was applied to EBT2 film dosimetry of intensity modulated radiation therapy (IMRT) and intensity modulated arc therapy (IMAT). Method and Materials:EBT2 films were calibrated by a field‐by‐field method in 13 steps. All films were scanned by using flat‐bed scanners at one day after the irradiation. Seven characteristic curves obtained by the TCCA method were compared with those of a single channel acquisition (SCA) method. For clinical applications, the planar dose distributions of IMRT and IMAT plans were compared with dose distributions measured with EBT2 films. The film analyses were performed by applying both TCCA and SCA. We chose two IMRT plans and two Varian IMAT (RapidArc) plans, which were created by the BrainLAB i‐plan and Eclipse Varian treatment planning systems for IMRT and RapidArc, respectively. Results: The constancy of the characteristic curves obtained by TCCA was better than that of SCA. The most significant difference between the characteristic curves of TCCA and SCA was observed in a low dose range between 25 cGy and 100 cGy. The results of clinical cases demonstrated that the dose difference between the measured and planned doses in high dose gradient regions was smaller with TCCA than that with SCA. Conclusions: We showed that characteristic curves obtained by the TCCA method have a good constancy compared with those of SCA. The potential advantage of TCCA was seen in high dose gradient regions in clinically relevant IMRT and IMAT cases. Hence, EBT2 film dosimetry with the TCCA method can be used for high precision patient specific QA.